Orgenesis (ORGS) Announces CFO Resignation

On December 22, 2023, Mr. Elliot Maltz, the Chief Financial Officer, Treasurer and Secretary of Orgenesis (NASDAQ: ORGS), resigned from all positions he held with the Company to pursue other opportunities. Mr. Maltz will remain with the Company through December 31, 2023 to complete his transition of duties. Mr. Maltz’s decision to resign did not result from any disagreement with the Company, its management or its board of directors on any matter, whether related to the Company’s operations, policies, practices or otherwise.

On December 28, 2023, the Company appointed Victor Miller as its Chief Financial Officer, effective January 2, 2024. Mr. Miller, 54, previously served as Chief Financial Officer and Secretary at Hycor Biomedical LLC. (“HYCOR”), an in vitro allergy diagnostic company, from 2014 to May 2023. Mr. Miller has over 30 years of healthcare and finance industry experience, including 14 years leading finance functions at early-stage life science companies.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Elroy Air wins $46M U.S. Army contract for cargo drone system
• loanDepot receives NYSE non-compliance notice over stock price